Suppr超能文献

极体 array CGH 预测相应卵母细胞的状态。第一部分:临床结果。

Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results.

机构信息

Department of Genetics and Cell Biology, Research Institute GROW, Faculty of Health, Medicine and Life Sciences, Maastricht University, PO Box 5800, Maastricht, AZ 6202, The Netherlands.

出版信息

Hum Reprod. 2011 Nov;26(11):3173-80. doi: 10.1093/humrep/der294. Epub 2011 Sep 9.

Abstract

BACKGROUND

Several randomized controlled trials have not shown a benefit from preimplantation genetic screening (PGS) biopsy of cleavage-stage embryos and assessment of up to 10 chromosomes for aneuploidy. Therefore, a proof-of-principle study was planned to determine the reliability of alternative form of PGS, i.e. PGS by polar body (PB) biopsy, with whole genome amplification and microarray-based comparative genomic hybridization (array CGH) analysis.

METHODS

In two centres, all mature metaphase II oocytes from patients who consented to the study were fertilized by ICSI. The first and second PBs (PB1and PB2) were biopsied and analysed separately for chromosome copy number by array CGH. If either or both of the PBs were found to be aneuploid, the corresponding zygote was then also processed by array CGH for concordance analysis.

RESULTS

Both PBs were biopsied from a total of 226 zygotes from 42 cycles (average 5.5 per cycle; range 1-15) in 41 couples with an average maternal age of 40.0 years. Of these, the ploidy status of the zygote could be predicted in 195 (86%): 55 were euploid (28%) and 140 were aneuploid (72%). With only one exception, there was at least one predicted aneuploid zygote in each cycle and in 19 out of 42 cycles (45%), all zygotes were predicted to be aneuploid. Fresh embryos were transferred in the remaining 23 cycles (55%), and one frozen transfer was done. Eight patients had a clinical pregnancy of which seven were evolutive (ongoing pregnancy rates: 17% per cycle and 30% per transfer). The ploidy status of 156 zygotes was successfully analysed by array CGH: 38 (24%) were euploid and 118 (76%) were aneuploid. In 138 cases complete information was available on both PBs and the corresponding zygotes. In 130 (94%), the ploidy status of the zygote was concordant with the ploidy status of the PBs and in 8 (6%), the results were discordant.

CONCLUSIONS

This proof-of-principle study indicates that the ploidy of the zygote can be predicted with acceptable accuracy by array CGH analysis of both PBs.

摘要

背景

几项随机对照试验并未显示出胚胎植入前遗传学筛查(PGS)活检和评估多达 10 条染色体非整倍体的益处。因此,计划进行一项原理验证研究,以确定替代形式的 PGS(即通过极体活检、全基因组扩增和基于微阵列的比较基因组杂交分析进行 PGS)的可靠性。

方法

在两个中心,同意参与研究的患者的所有成熟的中期 II 卵母细胞均通过 ICSI 受精。分别对第一极体(PB1)和第二极体(PB2)进行活检,并通过微阵列比较基因组杂交分析(array CGH)单独分析染色体拷贝数。如果一个或两个极体显示为非整倍体,则相应的受精卵也通过 array CGH 进行一致性分析。

结果

从 41 对夫妇的 42 个周期(平均每个周期 5.5 个;范围 1-15)中总共获得了 226 个受精卵,平均母亲年龄为 40.0 岁。其中,195 个(86%)受精卵的倍性状态可预测:55 个为整倍体(28%),140 个为非整倍体(72%)。除了一个例外,每个周期中至少有一个预测的非整倍体受精卵,在 19 个周期(45%)中,所有受精卵均预测为非整倍体。在剩余的 23 个周期(55%)中移植了新鲜胚胎,其中一个周期进行了冷冻移植。8 名患者有临床妊娠,其中 7 名持续妊娠(每个周期的妊娠率为 17%,每个移植周期的妊娠率为 30%)。通过 array CGH 成功分析了 156 个受精卵的倍性状态:38 个(24%)为整倍体,118 个(76%)为非整倍体。在 138 例中,两个极体和相应受精卵的完整信息均可用。在 130 例(94%)中,受精卵的倍性状态与极体的倍性状态一致,在 8 例(6%)中不一致。

结论

这项原理验证研究表明,通过对两个极体进行 array CGH 分析,可以以可接受的准确性预测受精卵的倍性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18ee/3196878/c006be4c00ff/der29401.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验